Cargando…
Visual hallucinations in Alzheimer's disease do not seem to be associated with chronic hypoperfusion of to visual processing areas V2 and V3 but may be associated with reduced cholinergic input to these areas
BACKGROUND: Up to 20% of patients with AD experience hallucinations. The pathological substrate is not known. Visual hallucinations (VH) are more common in dementia with Lewy bodies (DLB). In autopsy studies, up to 60% of patients with AD have concomitant Lewy body pathology. Decreased perfusion of...
Autores principales: | Sinclair, Lindsey Isla, Kumar, Amit, Darreh-Shori, Taher, Love, Seth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6740037/ https://www.ncbi.nlm.nih.gov/pubmed/31511061 http://dx.doi.org/10.1186/s13195-019-0519-7 |
Ejemplares similares
-
CSF and Plasma Cholinergic Markers in Patients With Cognitive Impairment
por: Karami, Azadeh, et al.
Publicado: (2021) -
Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs
por: Kumar, Rajnish, et al.
Publicado: (2016) -
Fibrillar β-amyloid 1-42 alters cytokine secretion, cholinergic signalling and neuronal differentiation
por: Malmsten, Linn, et al.
Publicado: (2014) -
Visually Driven Activation in Macaque Areas V2 and V3 without Input from the Primary Visual Cortex
por: Schmid, Michael C., et al.
Publicado: (2009) -
Hallucinations and conscious access to visual inputs in Parkinson’s disease
por: Lefebvre, Stéphanie, et al.
Publicado: (2016)